[Pathophysiology of hepatic fibrosis].
Murawaki
Y
Y
Second Department of Internal Medicine, Tottori University School of Medicine.
Kawasaki
H
H
D000818:Animals; D002908:Chronic Disease; D016207:Cytokines / Q000502:physiology; D016326:Extracellular Matrix Proteins / Q000096:biosynthesis; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D007371:Interferon-gamma / Q000627:therapeutic use; D008099:Liver / Q000378:metabolism; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D020778:Matrix Metalloproteinase 2 / Q000502:physiology; D019714:Tissue Inhibitor of Metalloproteinases / Q000494:pharmacology
D016207:Cytokines; D016326:Extracellular Matrix Proteins; D019714:Tissue Inhibitor of Metalloproteinases; D007334:Insulin-Like Growth Factor I; D007371:Interferon-gamma; D020778:Matrix Metalloproteinase 2